New Key Statistics Module, Z-Score and F-Score
SZSE:300841 Key Ratios
Market Cap ¥ M | 7,814.62 |
Enterprise Value ¥ M | 7,268.71 |
P/E(ttm) | 14.27 |
PE Ratio without NRI | 12.85 |
Forward PE Ratio | 9.61 |
Price/Book | 2.29 |
Price/Sales | 4.74 |
Price/Free Cash Flow | 18.94 |
Price/Owner Earnings | 22.58 |
Payout Ratio % | 0.44 |
Revenue (TTM) ¥ M | 1,647.00 |
EPS (TTM) ¥ | 4.12 |
Beneish M-Score | -2.45 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 23.40 |
y-y EBITDA Growth Rate % | 16.80 |
EV-to-EBIT | 11.47 |
EV-to-EBITDA | 11.47 |
PEG | 0.55 |
Shares Outstanding M | 132.95 |
Net Margin (%) | 33.15 |
Operating Margin % | 41.99 |
Pre-tax Margin (%) | 38.14 |
Quick Ratio | 4.49 |
Current Ratio | 4.86 |
ROA % (ttm) | 13.48 |
ROE % (ttm) | 15.70 |
ROIC % (ttm) | 21.47 |
Dividend Yield % | 3.40 |
Altman Z-Score | 11.82 |
SZSE:300841 Number of Guru Trades
SZSE:300841 Volume of Guru Trades
Gurus Latest Trades with SZSE:300841
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300841 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Kanghua Biological Products Co Ltd Insider Transactions
No Available Data